Related Experiment Video

Updated: Jul 7, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K

Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and

Samuel W Terman1, Laura Kirkpatrick2,3, Wesley T Kerr1,2,4

  • 1Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.

Epilepsia
|December 23, 2023
PubMed

Insights

Optimizing epilepsy treatment involves rigorous preclinical screening and innovative clinical trials. Future therapies aim to be disease-modifying, improving quality of life beyond just seizure suppression.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Epilepsy diagnosis, monitoring, and treatment require continuous optimization.
  • Current approaches focus on seizure suppression, but a broader impact is needed.

Purpose of the Study:

  • To review challenges and future directions in epilepsy therapeutics and diagnostics.
  • To highlight the shift towards disease-modifying treatments and improved quality of life.

Main Methods:

  • Preclinical screening of therapeutic candidates in animal models, focusing on avoiding seizure aggravation.
  • Discussion of clinical trial design, regulatory logistics, and biomarker development.
  • Examination of strategies for targeting nonseizure outcomes.

Main Results:

  • Identification of critical factors in preclinical drug development to prevent paradoxical seizure worsening.
  • Analysis of hurdles and solutions in clinical trial execution for epilepsy interventions.
  • Emphasis on developing biomarkers and treatments that modify the disease course.

Conclusions:

  • Epilepsy treatment is evolving beyond seizure suppression to address the disease's broader impact on quality of life.
  • Future therapeutic strategies must incorporate nonseizure outcomes like cognitive and functional improvements.
  • A comprehensive approach from drug discovery to translational application is essential for advancing epilepsy care.
Keywords:
antiepileptogenesisantiseizure medicationsbiomarkersclinical trialscomorbiditiesepilepsy

More Related Videos

Performing Behavioral Tasks in Subjects with Intracranial Electrodes12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

11.4K
Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.0K

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
191
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
412
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
369
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
581